Jaguar Health, Inc. (NASDAQ:JAGX) | Finanzwire

Basculer en Français

9476	Companies
185464	Keywords
117811	Articles
99314	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 07/10/2025 at 14:35, 4 months 25 days ago

Jaguar Health Expands Study on Canalevia-CA1 for Dogs

FDA Approval Jaguar Health Canalevia-CA1 Animal Health Dog Diarrhea
PRESS RELEASE

published on 07/10/2025 at 14:30, 4 months 25 days ago

Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
Jaguar Health, Inc. in talks with animal health partners to bring Canalevia to global market for general diarrhea in dogs. CEO presents at conference to discuss updates on Canalevia-CA1

Jaguar Health Conference Canalevia Animal Health Partners General Diarrhea
BRIEF

published on 07/08/2025 at 15:05, 4 months 27 days ago

Peru Grants Coca Research Rights to Magdalena Biosciences

Mental Health Jaguar Health Magdalena Biosciences Coca Research Peru Partnership
PRESS RELEASE

published on 07/08/2025 at 15:00, 4 months 27 days ago

Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indic
Jaguar Health announces agreement for research on coca plants to develop plant-based drugs for mental health and CNS indications, focusing on fair benefits sharing and traditional medicine

Mental Health Jaguar Health Coca Plants Plant-based Drugs Benefits Sharing
BRIEF

published on 06/30/2025 at 15:05, 5 months 4 days ago

Jaguar Health's Crofelemer Shows Promising Results in Reducing Parenteral Nutrition

Crofelemer Jaguar Health Regulatory Approvals Intestinal Failure Parenteral Nutrition
PRESS RELEASE

published on 06/30/2025 at 15:00, 5 months 4 days ago

Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient
Initial proof-of-concept results show crofelemer's efficacy in reducing TPN for intestinal failure patients. Jaguar seeking partnerships for drug development and commercialization

Crofelemer Drug Development Jaguar Health TPN Reduction Intestinal Failure
BRIEF

published on 06/30/2025 at 14:29, 5 months 4 days ago

Jaguar Health: FDA Dialogue and Strategic Trials

Crofelemer Clinical Trials Jaguar Health Breast Cancer FDA Meeting
PRESS RELEASE

published on 06/30/2025 at 14:24, 5 months 4 days ago

Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Buy recommendation on Jaguar Health Inc (ISIN: US47010C8055) to USD 40 target price post-positive breast cancer trial subgroup results. Plans for FDA approval through pivotal trial and orphan drug designation

Jaguar Health Inc FDA Approval First Berlin Equity Research Orphan Drug Designation Pivotal Trial
BRIEF

published on 06/26/2025 at 15:05, 5 months 8 days ago

Jaguar Health to Incorporate Cryptocurrency into Treasury Reserves

Digital Assets Jaguar Health Cryptocurrency Treasury Reserve Crofelemer Programs
PRESS RELEASE

published on 06/26/2025 at 15:00, 5 months 8 days ago

Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset
Jaguar Health, Inc. diversifies treasury holdings with long-term digital store of value through including cryptocurrency as a reserve asset. Company aims to safeguard against inflation and assesses potential benefits for core development programs

Inflation Jaguar Health Cryptocurrency Treasury Reserve Asset Digital Store Of Value

Accesswire

Published on 12/05/2025 at 14:00, 17 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 17 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 11 hours 42 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 11 hours 47 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 13 hours 17 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 13:45, 31 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 1 hour 17 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 1 hour 17 minutes ago

Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 2 hours 11 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 2 hours 16 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre

Les Echos

Published on 12/05/2025 at 08:45, 5 hours 32 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 20 hours 17 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 20 hours 32 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 20 hours 32 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 7 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE